知的所有権、COVID-19と次のパンデミック<br>Intellectual Property, COVID-19 and the Next Pandemic : Diagnosing Problems, Developing Cures

個数:
電子版価格
¥23,331
  • 電子版あり

知的所有権、COVID-19と次のパンデミック
Intellectual Property, COVID-19 and the Next Pandemic : Diagnosing Problems, Developing Cures

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Hardcover:ハードカバー版/ページ数 422 p.
  • 言語 ENG
  • 商品コード 9781009282383
  • DDC分類 346.0486

Full Description

This volume assesses the role of intellectual property in pandemic times through lessons learned from COVID-19. Authored by an international roster of experts, chapters diagnose causes for the inequitable distribution of lifesaving COVID-19 vaccines and offer concrete suggestions for reform. From delinking vaccine development from monopoly rights in technology, to enhanced legal requirements under national and international law for sharing publicly funded technologies, to requiring funding from rich nations to former colonies to build local vaccine manufacturing capacity in low and middle-income countries (including those in Africa), this work highlights timely IP reforms that prepare us for the next pandemic. This title is also available as Open Access on Cambridge Core.

Contents

Introduction: Intellectual property and 'the lost year' of COVID-19 Deaths Madhavi Sunder and Haochen Sun; Part I. Reconsidering Key Theoretical and Policy Issues: 1. New and heightened public-private quid pro quos: leveraging public support to enhance private technical disclosure Peter Lee; 2. Global medical war chest Lawrence O. Gostin; 3. COVID-19 and boundary-crossing collaboration Laura G. Pedraza-Fariña; 4. Legal paradigms and the politics of global COVID-19 vaccine access Matthew M. Kavanagh and Renu Singh; Part II. Boosting Low-Income Countries' Capacities for Protecting Public Health: 5. Fostering production of pharmaceutical products in developing countries William Fisher, Ruth Okediji and Padmashree Gehl Sampath; 6. Patent philanthropy Haochen Sun; 7. Beyond traditional IP: addressing regulatory barriers Cynthia M. Ho; 8. Capability approach to developing global health initiatives for equitable access to vaccines Calvin WL Ho; Part III. Alternative Means of Fighting Pandemics: 9. Planning for pandemic and epidemic-related scarcity of medicines Sapna Kumar & Ana Santos Rutschman; 10. Improving global governance of pandemic response: lessons from COVID-19 Jayashree Watal; 11. Compelling trade secret sharing David S. Levine & Joshua D. Sarnoff; 12. Voluntary intellectual property pledges and COVID-19 Jorge L. Contreras; Part IV. Toward Dynamic Protection of Public Health in China, Africa and Latin America: 13. The TRIPS waiver and the global pandemic response Peter K. Yu, China; 14. COVID-19 exclusion, policy contagion, and colonial hangover in Africa Olufunmilayo Arewa; 15. Technology transfer for production of COVID-19 vaccines in Latin America Kenneth C. Shadlen.

最近チェックした商品